Today Brightlabs has general methods for more than 15 different generic nitrosamines (i.e. N-Nitrosodimethylamine [NDMA], N-Nitrosomethylethylamine [NMEA], Nitrosodiisopropylamine [NdiPA], and many more). By using multiple techniques like GC-MS/MS and LC-APCI-MS/MS very low level, detection limits, as low as 1 ppb, can be achieved.
Secondly there are multiple API specific nitrosamines which can be determined, like N-Nitroso-betahistine, N-Nitrosofluoxetine, N-Nitrosoaripirazole, 1-(2,3-Dichlorophenyl)-4-nitrosopiperazine and many more.
Brightlabs is able to quickly develop and validate a nitrosamine method, specific for your product accepted by regulatory authority.
Want to know more, send us an email and download our brochure.